Exchange: NASDAQ·Updated 04:45 AM EDT
NUVL logo

NUVLNuvalent Inc - Ordinary Shares - Class A

$123.30
$0.22
(0.18%)
Pre-Market
Prev Close $123.52
EarningsAug 6
Mkt Cap$9.76B
Vol32.00

About

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
228

Frequently Asked Questions

What is Market Cap of Nuvalent Inc - Ordinary Shares - Class A?
What is the 52-week high for Nuvalent Inc - Ordinary Shares - Class A?
What is the 52-week low for Nuvalent Inc - Ordinary Shares - Class A?
What is Nuvalent Inc - Ordinary Shares - Class A stock price today?
What was Nuvalent Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Nuvalent Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Nuvalent Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Nuvalent Inc - Ordinary Shares - Class A?
How many employees does Nuvalent Inc - Ordinary Shares - Class A have?

Advertisement|Remove ads.